Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019
View
Cirrhosis & Complications
4
Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020
View
Cirrhosis & Complications
4
Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020
View
Cirrhosis & Complications
4
Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020
View
Cirrhosis & Complications
4
Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020
View
Cirrhosis & Complications
6
Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019
